Skip to main content

PSMA PET Imaging in Patients with Oligometastatic Prostate Cancer

Interview with the Innovators
PET/CT Imaging in Prostate Cancer Patients
Videos — November 15, 2021
Dr Neal Shore discusses the importance of PSMA PET imaging across a range of PSA values and how PYLARIFY® (piflufolastat F 18) will affect imaging of patients with oligometastatic prostate cancer.

Related Items

Patients Are at the Heart of Everything We Do
January 2024, Vol 14, No 1
Interview with the Innovators
Evolving Adjuvant Treatment Landscape for HR+/HER2- Early Breast Cancer
By Nadia Harbeck, MD, PhD
Videos
Interview with the Innovators
New Developments on Prognostic Markers for Patients With Early Breast Cancer
By Nadia Harbeck, MD, PhD
Videos
Interview with the Innovators
Recent Clinical Trials of Neoadjuvant Immunotherapy in Breast Cancer
By Nadia Harbeck, MD, PhD
Videos
Interview with the Innovators